Recently, Han et al. reported that TMEM232 is overexpressed in the skin tissues of AD patients and mice, promoting inflammatory responses via the NF-κB and STAT3 pathways, which exacerbates the inflammatory environment and results in the formation of AD-like lesions [46]. The gene discussed is STAT3; the disease is Alzheimer disease.